Vigilant Capital Management, LLC Pure Bioscience, Inc. Transaction History

Vigilant Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 Apr 04, 2018	SELL	$0.58 - $1.01 $1,160 - $2,020	-2,000 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$0.92 - $1.15 $1,840 - $2,300	2,000	2,000 $2,000

Ticker PURE
Exchange OTC
Sector Consumer Defensive
Industry Household & Personal Products
Shares Outstandng 88,023,104
Market Cap $8.8M
Description
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual prot...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.